Company Filing History:
3 out of 3,384 
1 out of 1 Years Active: 2016-2018
Title: Michael Marie Kaufman-Schofield: Innovator in Nonribosomal Peptide Synthesis
Introduction
Michael Marie Kaufman-Schofield is a notable inventor based in Ann Arbor, Michigan. He has made significant contributions to the field of biotechnology, particularly in the area of nonribosomal peptide synthesis. With a total of three patents to his name, Kaufman-Schofield's work has the potential to impact various applications in medicine and microbiology.
Latest Patents
Kaufman-Schofield's latest patents include innovative approaches to the biosynthetic pathway for nonribosomal peptide synthetases (NRPS) derived drugs. One of his key inventions provides polynucleotide sequences that are useful for heterologous expression in microbial hosts, facilitating the synthesis of NRPS-derived drugs. This patent also outlines methods for producing ET-743, a significant NRPS-derived drug. Another patent focuses on Baulamycins, detailing compositions and methods for inhibiting bacterial infections using specific compounds.
Career Highlights
Throughout his career, Kaufman-Schofield has worked with prestigious institutions, including the University of Michigan. His research has contributed to advancements in the understanding and application of nonribosomal peptides, which are crucial in developing new therapeutic agents.
Collaborations
Kaufman-Schofield has collaborated with esteemed colleagues such as David H. Sherman and Sunit Jain. These partnerships have enhanced his research and expanded the impact of his inventions in the scientific community.
Conclusion
Michael Marie Kaufman-Schofield is a prominent figure in the field of biotechnology, with a focus on nonribosomal peptide synthesis. His innovative patents and collaborations reflect his commitment to advancing scientific knowledge and developing new therapeutic solutions.